CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 4 Open-market buy Director bought 5,000,000 shares at $1.00 ($5,000,000)
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Delisting notice · Regulation FD disclosure
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 76,344 shares at an average $1.87 ($142,779)
- 8-K Event Material agreement · Regulation FD disclosure
Page 1 of 16 · 315 filings